نتایج جستجو برای: ovarian hyper stimulation syndrome

تعداد نتایج: 946874  

Journal: :international journal of reproductive biomedicine 0
leili safdarian shohre movahedi ashraf aleyasine marzie aghahosaini parvin fallah zahra rezaiian

background: despite numerous developments in the field of assisted reproduction the implantation rate remains low .recent studies suggested that local injury to endometrium in controlled ovarian hyper stimulation cycle improves implantation rate. studies have attempted to intervene in the development of endometrium. objective: the aim of the present study was the exploration of the possibility ...

Journal: :Human reproduction 2012
B Lledo J Guerrero J A Ortiz R Morales J Ten J Llacer J Gimenez R Bernabeu

BACKGROUND Fragile X syndrome is associated with low ovarian reserve and poor ovarian response. The aim of this study was to investigate whether CGG repeats on the fragile X mental retardation 1 (FMR1) gene have predictive value for ovarian response to stimulation with gonadotrophins and for clinical outcome in our oocyte donation program. METHODS Oocyte donor candidates were selected accordi...

بالاغفاری, جواد, قره گزلو , محمد, نظری , زینب,

Hyper IgE syndrome (Job’s syndrome) is a primary immunodeficiency disease with recurrent infections especially staphylococcal, coarse face, skeletal abnormality and significant increase in serum IgE level (IgE >2000IU/ml). We present a 16 years old boy admitted with chronic cough, dyspnea, eczema and pneumatocele. He had a history of chronic dermal infection since 1 month after birth. The dia...

2011
P. Devroey P. Adriaensen

If ovarian stimulation is performed accordingly to new strategies available, the occurrence of ovarian hyperstimulation syndrome will be eradicated. The strategy is to stimulate all women with GnRH antagonist and in case of need to -induce final egg maturation with GnRH agonist.

Amin Soleymanian Fahimeh Ramezani Tehrani, Fatemeh Rezayat Mehri Hajiaghayi Mehrnaz Mesdaghi Nazanin Ghasemi

Background: Polycystic Ovarian Syndrome (PCOS) is a pro-inflammatory condition that supports the development of metabolic aberration and ovarian dysfunction. Chronic inflammation and the increased levels of androgens in this group of patients and their impact on the immune system may increase the risk of developing malignancies, including ovarian cancer. Thus, we interacted ovarian tumor cells ...

Journal: :international journal of reproductive biomedicine 0
ashraf moini fatemeh javanmard bita eslami najmeh aletaha

background: polycystic ovarian syndrome (pcos) is a condition associated with chronic anovulation, insulin resistance and androgen excess. women with this syndrome are at increased risk of metabolic syndrome. objective: the aim of the present study was to determine the prevalence of metabolic syndrome (mbs) in women with pcos referred to arash hospital in different ages and body mass index (bmi...

2013
Bushra Fiza Rati Mathur Pushpendra Saraswat

Keywords: Polycystic ovarian syndrome PCOS Anti-mullerian hormone AMH PCOD Original Article Polycystic ovarian syndrome is a complex heterogeneous disorder of unknown etiology and shows mild to severe degree of signs and symptoms affecting the reproductive, endocrine and metabolic functions. Anti-mullerian hormone, a dimeric glycoprotein belonging to the transforming growth factor–beta superfam...

Journal: :international journal of reproductive biomedicine 0
mahmoud hashemitabar babak ghavamizadeh fatemea javadnia esmaiel sadain

background: the luteal phase defect is a common event following the ovarian stimulation. the aim of the present study was to evaluate the use of human chorionic gonadotropine (hcg) and progesterone hormones to improve the luteal phase defect. materials and methods: 60 mice were superovulated routinely with human menopausal gonadotropin (hmg) (7.5u) and hcg (10u). the mice were mated and divided...

2015
Junwei Qu Yena Che Pei Xu Yanjie Xia Xiaoke Wu Yong Wang

BACKGROUND This research investigated the response of vascular active factors, vascular endothelial growth factor (VEGF) and angiotensin-II (AT-II) to ovarian stimulation during 24 hours in patients with polycystic ovary syndrome (PCOS). MATERIALS AND METHODS In this clinical trial study, 52 patients with PCOS and 8 control cases were stimulated with human chorionic gonadotropin (HCG) on the ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید